Impact of Capitation Payment Models on Kidney Health Outcomes

Chronic kidney disease (CKD) affects 37 million Americans and leads to end-stage renal disease (ESRD), which accounts for over $50 billion in Medicare spending. This research team will evaluate the impact of the Center for Medicare and Medicaid Innovation’s Kidney Care Choices payment model on CKD care delivery and kidney health outcomes. The study results will provide novel evidence on the impact of capitation payments, which provide reimbursement on a per-member per-month basis.